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Cartilage oligomeric matrix protein (COMP), a se-
creted glycoprotein synthesized by chondrocytes,
regulates proliferation and type II collagen assembly.
Mutations in the COMP gene cause pseudoachondro-
plasia and multiple epiphyseal dysplasia. Previously,
we have shown that expression of D469del-COMP in
transgenic mice causes intracellular retention of
D469del-COMP, thereby recapitulating pseudoachon-
droplasia chondrocyte pathology. This inducible
transgenic D469del-COMP mouse is the only in vivo
model to replicate the critical cellular and clinical
features of pseudoachondroplasia. Here, we report
developmental studies of D469del-COMP-induced
chondrocyte pathology from the prenatal period to
adolescence. D469del-COMP retention was limited
prenatally and did not negatively affect the growth
plate until 3 weeks after birth. Results of immuno-
staining, transcriptome analysis, and qRT-PCR sug-
gest a molecular model in which D469del-COMP trig-
gers apoptosis during the first postnatal week. By 3
weeks (when most chondrocytes are retaining
D469del-COMP), inflammation, oxidative stress, and
DNA damage contribute to chondrocyte cell death by
necroptosis. Importantly, by crossing the D469del-
COMP mouse onto a Chop null background (Ddit3
null), thereby eliminating Chop, the unfolded protein
response was disrupted, thus alleviating both
D469del-COMP intracellular retention and premature
chondrocyte cell death. Chop therefore plays a signif-
icant role in processes that mediate D469del-COMP
retention. Taken together, these results suggest that
there may be an optimal window before the induction
of significant D469del-COMP retention during whichendoplasmic reticulum stress could be targeted. (Am
J Pathol 2012, 180:727–737; DOI: 10.1016/j.ajpath.2011.10.035)
Cartilage oligomeric matrix protein (COMP) is an extra-
cellular matrix (ECM) protein found primarily in cartilage
and other musculoskeletal tissues.1–10 The COMP gene
(previously PSACH; also known as TSP5) is the fifth mem-
ber of the thrombospondin family and is a homopen-
tamer.1–7 It is composed of a N-terminal pentamerization
domain, four EGF-like repeats, seven type II calcium-
binding repeats, and a C-terminal globular domain.7
COMP has several potential functions including interact-
ing with other ECM molecules in the matrix, regulating
type II collagen fibril assembly, and enhancing chondro-
cyte attachment and proliferation.11–17
Mutations in COMP, which result in protein misfolding
and intracellular retention, cause two autosomal domi-
nant skeletal dysplasias: pseudoachondroplasia, a se-
vere dwarfing condition, and multiple epiphyseal dyspla-
sia (MED/EDM1), a milder disorder.18–23 Children with
pseudoachondroplasia have normal birth parameters,
but develop a waddling gait and have decelerating linear
growth by 2 to 3 years of age.24,25 Bone abnormalities
develop over time and include shortened limbs, brachy-
dactyly, and pectus carinatum.24,25 Early-onset osteoar-
thritis, affecting all of the joints, causes chronic pain,
often necessitating hip replacement in early adulthood.25
Although natural history studies have defined the clinical
progression of the pseudoachondroplasia phenotype, lit-
tle is known about the mechanism or mechanisms under-
lying the chondrocyte cellular phenotype that causes the
diminished bone growth. Most information about the in
vivo state is derived from bone biopsies of the pseudoa-
chondroplasia growth plate or from in vitro tissue culture
studies, and thus provides little mechanistic information.
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droplasia and MED/EDM1 patients show giant rough en-
doplasmic reticulum (rER) cisternae containing COMP
and other ECM proteins [collagen types II and IX and
matrilin 3 (MATN3)] that form an ordered matrix net-
work.2,13,19–40 The inability of mutant COMP to fold prop-
erly traps the protein in the ER, thereby allowing intracellular
matrix assembly.23,35,36,41 These matrix-filled cisternae oc-
cupy most of the chondrocyte cellular volume, ultimately
compromising chondrocyte cellular function and causing
premature chondrocyte cell death.13,18,19,27,32,35,36,39,41
Earlier pseudoachondroplasia mouse models have not
faithfully recapitulated the chondrocyte phenotype and
thus have not allowed for analysis of growth plate pathol-
ogy during skeletal development.42,43 To circumvent this
problem, we generated an inducible transgenic D469del-
COMP mouse that we have shown reproduces the char-
acteristic pseudoachondroplasia chondrocyte pathology
by 1 month of age, including intracellular retention of
COMP, types II and IX collagens, and MATN3, as well as
premature intracellular ECM assembly, growth plate ab-
normalities, and increased numbers of apoptotic chon-
drocytes.44 Here, we define the mechanism of chondro-
cyte loss and ontogeny of D469del-COMP retention and
cell death during prenatal and postnatal skeletal devel-
opment. Most importantly, we show that, in the absence
of Chop, D469del-COMP is not retained and D469del-
COMP-induced cell death is eliminated.
Materials and Methods
Generation of Constructs
Two plasmids, pTRE-COMP and pTET-On-ColII, were
generated as described previously44 and were used to
produce bigenic mutant D469del-COMP mice. Briefly,
the pTRE-COMP construct contains the coding sequence
of the human COMP (FLAG tag) gene driven by the
tetracycline responsive element (TRE) promoter. The
pTET-On-ColII construct contains the rtTA coding se-
quence driven by a type II collagen promoter.45
Generation of Bigenic Mice
Standard breeding was used to generate bigenic ani-
mals. Genotypes of the transgenic offspring were verified
using human COMP and rtTA-specific primers. Mice
were pre- and postnatally administered doxycycline (500
ng/mL) through drinking water (supplemented with 5%
sucrose). All animal studies were approved by the Animal
Welfare Committee of the University of Texas Medical
School at Houston.
Generation of Chop Null Bigenic Mice
Chop null mice were procured from Jackson Laboratories
and mated with D469del-COMP bigenic mice to obtain a
strain expressing D469del-COMP in a Chop null back-
ground.46 Genotypes of the Chop null mice were verified
using Chop-specific primers.46Growth Plate Analysis
Upper tibial growth plates were obtained from at least 10
different mice of each strain. Chondrocytes were counted
by marking each chondrocyte using Image-Pro software
version 4 (Media Cybernetics, Silver Spring, MD) at 4
magnification to visualize the entire growth plate. Five
measurements along the width of the growth plate were
obtained from different limbs, and the measurements
were then averaged as previously described.47
Immunohistochemistry
Hind limbs of D469del-COMP and C57BL/6 control mice
were collected and tibial growth plates were analyzed as
previously described.44 Briefly, the limbs were fixed in
95% ethanol for immunostaining for COMP [rabbit poly-
clonal antibody, 1:200 (Kamiya, Seattle, WA) or ab11056-
rat antibody, 1:100 (Abcam Cambridge, MA)], FLAG (Ab-
cam, Cambridge, MA), PCNA [93–1143 (Invitrogen,
Carlsbad, CA)], AIF [4642, 1:50 (Cell Signaling Technol-
ogy, Danvers, MA)], and H2AX [9718, 1:100 (Cell Signal-
ing)] or in 10% formalin for TUNEL staining. The COMP
rabbit antibody cross-reacts with both endogenous mouse
and transgenic human COMP, whereas the COMP rat an-
tibody is specific for human COMP. FLAG specifies the
recombinant human D469del-tagged COMP.
Retention Scoring
A scoring strategy was devised to measure the relative
amount of D469del-COMP retention in the growth-plate
chondrocytes of transgenic mice. Growth plates were
processed as described above and as described previ-
ously.47 Each chondrocyte in the visual field of images at
400 magnification was scored for retention in 10 sepa-
rate images. The scorer visually estimated the size of
D469del-COMP accumulation area, compared with the
area of the nucleus for each chondrocyte. An average
score was calculated from these images. Chondrocytes
were scored as follows: 1  no retention, 2  retention
area is less than that of the nucleus, 3  retention area is
the same size as the nucleus, and 4  retention area is
larger than the nucleus in each chondrocyte.
RNA Extraction and Real-Time qRT-PCR
Mice of various ages were collected and soft tissue was
removed from the skeleton at age embryonic day 15.5
(E15.5), or knee and elbow joints at postnatal day 1 (P1),
or knee joint at all other ages. Tissue was immediately
homogenized in TRIzol reagent (Sigma-Aldrich, St. Louis,
MO) and RNA was extracted according to the manufac-
turer’s protocol. Quantitative real-time RT-PCR (qRT-
PCR) was performed using an ABI 7700 sequence de-
tector (Applied Biosystems, Foster City, CA). DNA was
removed using amplification grade DNase (Invitrogen)
according to the manufacturer’s instructions. Each assay
was replicated three times, and each sample was mea-
sured in triplicate, including a control without reverse
transcriptase. The final data were normalized to Hprt1 
D469del-COMP Retention in Chondrocytes 729
AJP February 2012, Vol. 180, No. 2100 (percentage of the normalizer transcript). qRT-PCRwas
performed using standard methods and the following prim-
ers: Grp78 5=-CATGGTTCTCACTAAAATGAAGG-3= and
5=-GTAAGCTGGTACAGTAACAACTG-3=; Xbp-1 5=-GTC-
TGCTGAGTCCGCAGCAGGT-3= 5=-CAGACTCAGAAT-
CTGAAGAGGC-3=; Edem1 5=-AGTCAAATGTGGATAT-
GCTACGC-3= 5=-ACAGATATGATATGGCCCTCAGT-3=;
Chop 5=-TGCCTTTCACCTTGGAGAC-3= and 5=-CGT-
TTCCTGGGGATGAGATA-3=; Ero1B 5=-CGTCCTTTAAA-
TCCTTTGGCG-3= and 5=-ACACAAACCTTCTAGCCACG-
3=; GADD34 5=-AGAGAAGCCAGAATCACCTTG-3= and
5=-ACTGTGACTTTCTCAGCGAAG-3=; GADD45A 5=-CCG-
AAAGGATGGACACGGTG-3= and 5=-TTATCGGGGTCT-
ACGTTGAGC-3=; and Hprt1 (normalizer) 5=-CCTCAT-
GGACTGATTATGGACAG-3= and 5=-TCAGCAAAGAAC-
TTATAGCCCC-3=.
Microarray Analysis
Total RNA (300 ng) from both hind-limb knee joints of
each sample was purified using TRIzol reagent and
RNeasy columns (Qiagen, Valencia, CA). RNA was am-
plified using a total prep RNA amplification kit (Illumina,
San Diego, CA). RNA was assessed by RNA integrity
number (RIN number), and type II collagen was as-
sessed to verify that both the C57BL/6 and D469del-
COMP RNA preparations were primarily from chondro-
cytes. For each time point, three control and three
D469del-COMP animals were examined, to control for
variation in expression. In vitro transcription was per-
formed and biotinylated cRNA was synthesized by 14-
hour amplification with dNTP mix containing biotin-dUTP
and T7 RNA polymerase. Amplified cRNA was subse-
quently purified and concentration was measured. An
aliquot of 1.5 g of amplified products was loaded onto
Illumina Sentrix BeadChip mouse WG-6.v2 arrays, hy-
bridized at 58°C in an Illumina hybridization oven for 17
hours, washed, and incubated with streptavidin-Cy3 to
detect biotin-labeled cRNA on the arrays. Arrays were
dried and scanned with an Illumina BeadArray reader.
Data were analyzed using Illumina GenomeStudio soft-
ware. Clustering and pathway analysis were performed
with GenomeStudio and Ingenuity Pathway Analysis soft-
ware (Ingenuity Systems, Redwood City, CA), respec-
tively. A P value of 0.05 was considered significant.
The mRNAs were classified into functional categories.
Limb Length Measurements
Hind limbs were obtained from 12 control and 12 D469del-
COMP mice and the soft tissue was removed. The skeleton
was stored in 70% ethanol and then subjected to radio-
graphical examination. The limbs were attached to a grid to
ensure consistency and accuracy of measurements. Mea-
surements were made from end to end on both long bones
in the hind limb, using Image-Pro software, as previously
described.47 A t-test was used to compare tibial measure-
ments from control and D469del-COMP mice limbs.Skeletal Preparations
Mice were collected and the soft tissue removed and
then fixed overnight in 95% ethanol. Skeletons were
stained for 48 hours with Alcian Blue (0.015% solution in
20% acetic acid and 80% methanol), then transferred to
95% ethanol for 2 hours, and then to 2% KOH for 3 hours.
The mineralized bone was then stained with Alizarin Red
(0.005% in 1% KOH) for 3 hours. The skeleton was
cleared in 1% KOH in 20% glycerol for 48 hours and then
stored in a glycerol ethanol mixture (1:1).
Results
D469del-COMP Growth Plates Become
Disorganized and Thinner during Juvenile
Development
We first asked whether the presence of D469del-COMP
in our transgenic mouse causes growth plate abnormal-
ities over time. The growth plate organization was similar
in D469del-COMP and control mice until 2 weeks (P14;
Figure 1, A–C and G–I). At 3 weeks (P21; Figure 1, D and
J), more acellular gaps were seen and the growth plate
was thinner than control (Figure 1, M and N). By 4 weeks,
the growth plate continued to be thinner, compared with
control, and loss of chondrocytes was evident (Figure 1,
E, K, M, and N). At 2 months, when skeletal growth is
complete, the D469del-COMP growth plate had very few
chondrocytes, unlike the control (Figure 1, F and L).
Changes in the D469del-COMP growth plate are attrib-
uted to expression of D469del-COMP rather than to doxy-
cycline exposure, because all mice were subjected to the
same doxycycline treatment. These results indicate that
D469del-COMP expression causes loss of growth-plate
chondrocytes, which is evident by 3 weeks of age. There
Figure 1. Histomorphometric analysis of D469del-COMP growth plates
from E15 to 2 months of age. H&E staining of growth plates at various ages
in control C57BL/6 (A–F) and D469del-COMP (G–L) mice. D469del-COMP
and control growth plates are similar until P14 (D and J), when the growth
plates of D469del-COMP mice are more disorganized. Original magnification,
20 (A–L). M: Quantification of growth plate width. Growth plates from
D469del-COMP mice are narrower than those of controls at P21, 1 month,
and 2 months of age. N: Quantification of number of chondrocytes. Fewer
chondrocytes are present in the D469del-COMP growth plate, compared with
controls, at 1 and 2 months of age. *P  0.05, **P  0.01.
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plate height before this developmental time point.
D469del-COMP Retention Is First Evident in
Prenatal Growth-Plate Chondrocytes
We next asked when D469del-COMP becomes retained
in the chondrocytes of the developing growth plate. Pre-
viously, we showed that D469del-COMP is retained in the
rER and forms an ordered intracellular matrix composed
of collagens types II and IX and MATN3 in growth plates
from 1-month-old mice, identical to what is observed in
pseudoachondroplasia patient chondrocytes.21,44 In
these studies, a FLAG antibody recognizes the transgenic
D469del-COMP-FLAG protein and a COMP antibody rec-
ognizes both the endogenous murine and transgenic hu-
man COMP-FLAG. Few chondrocytes showed intracellular
retention at E15, compared with control (Figure 2, A and G).
Both the D469del-COMP and control chondrocytes show a
patchy distribution of COMP (Figure 2, A and G). Intracel-
lular retention was measured using the scoring methodol-
ogy described underMaterials and Methods and presented
schematically in Figure 2M (an example of D469del-COMP
growth-plate chondrocytes with a retention score of 4 is
presented in Figure 2N). The intracellular retention in-
Figure 2. Intracellular retention of COMP in growth plates of D469del-
COMP mice from E15 to 2 months of age. Immunostaining of D469del-COMP
(A–F) and control C57BL/6 (G–L) growth plates with FLAG (green) and
COMP (red) antibodies. Patchy intracellular retention (yellow indicates
merged image) begins before birth at E15; progressive intracellular
D469del-COMP accumulation is observed with increasing age. Control
C57BL/6 growth plates show no intracellular retention of COMP. Original
magnification, 20 (A–L). M: Scoring methodology. A numerical score
was assigned by visually comparing the cumulative size of D469del-
COMP-positive rER cisternae with the area of the nucleus. C, retention; N,
nucleus. N: Two examples of D469del-COMP growth-plate chondrocytes
with a retention score of 4. O: Quantitation of progressive intracellular
D469del-COMP in growth plates from E15 to 2 months of age. *P  0.05.creases, with many chondrocytes showing retention by P3;
almost all chondrocytes are retaining D469del-COMP by
P21 (Figure 2, B–D and O); In comparison, in the nontrans-
genic controls, all endogenous COMP is extracellular (Fig-
ure 2, G–L). This indicates that intracellular retention is a
progressive process with the maturing of the growth plate
and eventually encompasses all chondrocytes in the growth
plate.
To quantitate the progression of D469del-COMP reten-
tion, we developed a scoring system based on the area
of the COMP-positive intracellular retention relative to the
area of the nucleus as defined by DAPI staining (Figure
2B). This system was designed to compare the relative
amount of D469del-COMP retained in growth-plate chon-
drocytes at different developmental ages. There was a
significant increase in D469del-COMP retention starting
shortly after birth (P3), compared with that seen at E15.5
(Figure 2B). D469del-COMP retention continued to in-
crease significantly up to P14, at which point the levels
remained relatively constant, suggesting that a steady
state level had been attained.
Cell Death Is Detected Only at P21 When
Significant Intracellular D469del-COMP
Retention Is Present
Previously we showed that expression of D469del-COMP
in the mouse growth plate induces premature cell
death.44 Here, we define the onset and distribution of cell
death using TUNEL staining (Figure 3, G–L and S–X).
DAPI was used to localize the nucleus of each chondro-
cyte (Figure 3, A–F and M–R). Little or no cell death was
seen in the D469del-COMP and control growth plates
until P14, when it was restricted to the hypertrophic zone
(Figure 3). A significant increase in cell death affecting
chondrocytes throughout the D469del-COMP growth
plate was seen at P21 and older ages (Figure 3, J–L). In
contrast, in the control growth plates cell death was lim-
ited and restricted to the hypertrophic zone (Figure 3,
V–X). Cell death correlated with the presence of signifi-
cant accumulation of D469del-COMP in the growth-plate
chondrocytes (Figure 3, J–L, and Figure 2, D–F). Levels
of cell death remained high at 1 and 2 months of age
(Figure 3, K, L, and Y), corresponding to fewer chondro-
cytes in the growth plate (Figure 1M). These results sug-
gest that the level of intracellular retention of D469del-
COMP induces cell death, which translates into
significant loss of growth-plate chondrocytes.
Long Bones Are Significantly Reduced in
D469del-COMP Mice
Finally, we assessed how loss of growth-plate chondro-
cytes affects the mouse skeleton. Radiographical mea-
surements showed that the D469del-COMP tibia was
wider and 12% shorter than the control tibia (Figure 4).
The skeleton of D469del-COMP mice was smaller than that
of the controls (Figure 5, A and B). The skull, snout, fore
limbs, hind limbs, and phalanges of the D469del-COMP
mouse were reduced, compared with controls (Figure 5, C,
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a prominent sternum. These results indicate significant re-
duction in all of the bones derived from endochondral bone
formation; the reductions were similar to those observed in
pseudoachondroplasia patients.24,40
D469del-COMP Expression Induces a Proapoptotic
Environment before D469del-COMP Retention
and Cell Death Is Detected in the Growth Plate
To define the molecular mechanisms that contribute to
intracellular retention and chondrocyte cell death, we
Figure 3. Chondrocyte cell death in D469del-COMP and control growth
plates from mice at ages E15 to 2 months. TUNEL and DAPI staining of
D469del-COMP (A–L) and control C57BL/6 (M–X) growth plates. Cell death
in D469del-COMP and control growth plates is equivalent until P21, when
D469del-COMP cell death is increased, compared with control (J–L and
V–X). Original magnification, 20 (A–X). Arrowhead indicates increase
relative to control. Y: Quantitation of TUNEL-positive chondrocytes in
growth plates from P21 to 2 months of age. Cell death in D469del-COMP
growth plates is threefold higher at P21, fourfold higher at 1 month, and
twofold higher at 2 months of age, compared with controls. **P  0.01.analyzed the transcriptome from P1 and from 1-, 2-, 3-,
and 4-week-old hind-limb knee joints from transgenic and
control mice, using a microarray. Proapoptotic transcripts
were modestly elevated, and antiapoptotic transcripts
were slightly down-regulated at P1 (Table 1). Specifi-
cally, the transcripts from four prosurvival genes were
expressed at lower levels in D469del-COMP P1 mice:
Bag3 (0.8), Bcl2 (0.6), Bcl2l1 (0.5), and Bcl2l2
(0.7). In contrast, proapoptotic transcripts from five
genes were up-regulated: Casp8 (1.3), Bad (1.6),
Bax (1.3), and Chop (1.4 to 1.6). Generally, expres-
sion of genes encoding proteins involved in generation
of antioxidants and ROS were increased from 2 to 4
weeks (Table 1). Inflammatory gene expression spiked
at 3 weeks of age in the D469del-COMP mice, which
correlated with high levels of cell death in the growth
plate (Figure 3 and Table 1).
Figure 4. D469del-COMP limbs are shorter than C57BL/6 controls. A and B:
Radiographs of hind limbs from 1-month-old C57BL/6 (A) and D469del-
COMP (B) mice. C: Scatter plot of individual measurements. Horizontal bars
indicate means, and error bars indicate  SD. D469del-COMP mice have a
12% decrease in tibial length (P  0.000001). Tibial measurements were
taken from 12 limbs and the average length was calculated. A t-test was
used to compare D469del-COMP tibial length to control.
Figure 5. Skeletal elements of D469del-COMP and C57BL/6 control mice. A
and B: Whole skeletal preparations of C57BL/6 control (A) and D469del-
COMP (B) mice showing cartilage (Alcian Blue) and bone (Alizarin Red).
C–F: Lateral and superior images of the skull of C57BL/6 (C and E) and
D469del-COMP (D and F) mice. G–J: Fore and hind limbs of C57BL/6 (G and
I) and D469del-COMP (H and J) mice. K and L: Front paws of C57BL/6 (K)
and D469del-COMP (L) mice. Red and blue bars reflect skull measurements
of a C57BL/6 mouse, for comparison with D469del-COMP mouse.
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for genes involved in the UPR activation, ubiquitination,
proteasome activation, DNA damage repair, and cell cy-
cle regulation (Table 2). Expression of genes involved in
protein folding and binding of unfolded proteins was el-
evated at P1 and depressed at 4 weeks. Ubiquitin ligase
Table 1. Time-Dependent Altered mRNAs Involved in Cell Death
Genes P1
Apoptosis: antiapoptotic
Apip
Bag3 0.8
Bcl2 0.6
Bcl2l1 0.5
Bcl2l2 0.7
Bnip3l 1.2
Bcl2a1b
Bcl2a1d
Cfl1 1.6
Apoptosis: caspase recruitment domain
Casp1
Casp6
Casp8 1.3
Nol3 1.5
Apoptosis: proapoptotic
Bax
Bad 1.6
Apip
Chop 1.4
Antioxidants
Epx
Ttn 0.5
Mt3
ROS metabolism
Prg3
Prg2
Angptl7 0.2
Atox1 1.5
Dusp1 0.6
Foxm1 1.5
Glrx2
Sepp1 0.7
Stk25 0.8
Inflammatory response
Cd40
Ly96
Hdc 0.3
Pou2af1
Cd79b
Ear2 4
Ear3
Ear4
Ear6
Irf9 0.5
Includes articular and growth-plate cartilage.
Table 2. Time-Dependent Expression Trends of Genes Involved in
Gene P
Protein folding, binding of unfolded protein 1
Ubiquitin ligase (E1) 1
Component of the proteasome PSMB8
Bind to damaged DNA 1
DNA repair (Chaf1a, Fen1, Polh, Ung) 1
Cell cycle control in response to DNA damage
(Gadd45a, Smc3, Rbbp4)Includes articular and growth-plate cartilage. 1 indicates increased express(E1) expression was elevated at P1; PSMB8, a compo-
nent of the proteasome, was expressed at a higher level
in 2- and 4-week-old D469del-COMP mice, compared
with controls. mRNAs for proteins that bind to damaged
DNA were elevated from P1 to 4 weeks, and DNA repair
gene mRNAs were increased from P1 to 2 weeks
ative Stress, and Inflammation in MT-COMP Mice
eek 2 weeks 3 weeks 4 weeks
2 1.6
0.8
0.8
.2 0.8
1.2
.7 0.8 0.6
0.8 0.7
.3 0.3
1.5
0.8
1.4 0.8
.3 0.6 0.8
0.8
.6
7 2
1.7 0.6
.9
5 2
4 1.7
0.4 0.6
1.6
0.5
.8 1.6 1.8
0.6
.6 1.6
.5
1.5 1.2
4.2
3.5
6.2 2
5.2 2.6
10.4
14.6
2.7
biquitination, Proteasome, and DNA Damage in MT-COMP Mice
P7 P14 P21 1 month
2
1 1
1 1 1 1
1
1 1, Oxid
1 w
1
1
2
1
1
1
1
3
0
1
1UPR, U
1ion; 2 indicates decreased expression.
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regulate the cell cycle in response to DNA damage were
modestly increased at 2 and 4 weeks (Gadd45a, Smc3,
and Rbbp4). Changes in mRNA expression of selected
genes of the UPR, including Chop, Gadd34, and Ero1B,
were confirmed using qRT-PCR analysis (data not
shown). Taken together, these trends indicate that a pro-
apoptotic environment is established early and that oxi-
dative stress, DNA damage, and inflammation collec-
tively promote chondrocyte cellular death. The observed
changes in DNA damage response, UPR, and ubiquitin-
proteasome mRNAs support this model.
D469del-COMP Is Not Retained in the Absence
of Chop
Microarray transcriptome analysis showed a modest in-
crease in Chop mRNA at P1 and P7 that was validated by
qRT-PCR. Because Chop plays a significant role in UPR
pathway and cell death, we generated a mouse line that
expresses D469del-COMP on a Chop/ background
(Jackson Laboratory). The growth plates from these mice
were analyzed at 1 month for intracellular retention of
D469del-COMP, using a human COMP-specific anti-
body. In the absence of Chop, D469del-COMP was not
retained in the chondrocyte, but was observed in a peri-
cellular halo around the chondrocyte (Figure 6, G–I).
However, as expected, D469del-COMP was distinctly ev-
ident within each chondrocyte in the D469del-COMP
growth plate in mice expressing Chop (Figure 6, D–F), in
contrast to controls (Figure 6, A and B).44 Because the
loss of Chop permits D469del-COMP to be exported, we
asked whether the export of D469del-COMP alleviates
other aspects of the pseudoachondroplasia chondrocyte
pathology. We assessed proliferation and cell death by
PCNA and TUNEL staining in the Chop/ D469del-
COMP growth plates at 1 month of age. We found that
PCNA and TUNEL staining was significantly reduced in
the Chop/ D469del-COMP growth plate, compared
with levels in the D469del-COMP mouse, but similar to
levels in the control (Figure 6, J–O). Several inflammatory-
related transcripts that were up-regulated in the D469del-
COMP mice were down-regulated by twofold (Ear2, Ear3,
Ear4, Ear6, and Irf9) in the Chop/ D469del-COMP
mice. These data indicate that these inflammatory-related
transcripts are involved in the pseudoachondroplasia
chondrocyte pathological process, consistent with the
proposed model.
To further investigate the effects of the absence of
Chop on ER stress genes, the expression of Chop, Xbp1,
Gadd45a, Gadd34, Ero1b, Grp78, and Edem1 was mea-
sured. D469del-COMP expression up-regulated the tran-
script level of Chop, Xbp1, Gadd45a, Ero1b, and Grp78 in
mice at 1 month of age, which was consistent with the
microarray findings (Table 1 and Figure 7). In Chop/
D469del-COMP mice, the expression of Xbp1, Gadd45a,
and Gadd34 was reduced, compared with D469del-
COMP mice (Figure 7). These findings show that Chop
plays a significant role in regulating the UPR genes that
are up-regulated in D469del-COMP chondrocytes.D469del-COMP Increases Cell Death-Inducing
Factor (AIF) and Phosphorylated Histone H2AX
(H2AX) Associated with Necroptosis
Our in vitro analysis of the UPR, stimulated by D469del-
COMP, showed up-regulation of markers of necropto-
sis.48 Necroptosis, a form of programmed death medi-
ated through caspase-independent mechanisms, involves
Figure 6. COMP immunostaining of C57BL/6, D469del-COMP, and Chop
null D469del-COMP growth plates. DAPI staining marks the nucleus. A
human specific COMP antibody (Abcam) was used. A–I: COMP and DAPI
staining of C57BL/6, D469del-COMP, and Chop/ D469del-COMP growth
plates of 1-month-old mice. D469del-COMP was retained in all D469del-
COMP chondrocytes (D–F) but had a pericellular distribution in the absence
of Chop (G–I). J–L: PCNA immunostaining of growth plates of 1-month-old
C57BL/6 (J), D469del-COMP (K), and Chop/ D469del-COMP (L) mice.
Decreased PCNA immunostaining is seen in D469del-COMP, compared with
control and Chop/ D469del-COMP mice. M–O: TUNEL immunostaining of
growth plates of 1-month-old C57BL/6 (M), D469del-COMP (N), and
Chop/ D469del-COMP (O) mice. Increased number of apoptotic chondro-
cytes are found in D469del-COMP, compared with control and Chop/
D469del-COMP growth plates. Original magnification,40 (A–I),20 (J–O).rupture of the plasma membrane.49–52 To determine
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COMP growth plate, we assessed the level of AIF and
H2AX, which are associated with necroptosis. AIF is
increased in the D469del-COMP growth plate at 1 month,
compared with control (Figure 8, A–L). Additionally,
cleaved AIF necessary for necroptosis execution was
observed in the nucleus of D469del-COMP chondrocytes
but not in controls. Moreover, H2AX (the binding partner
of AIF) was up-regulated in the D469del-COMP growth
plate (Figure 8, M–O). Cleaved caspase 3 was not de-
tected in either D469del-COMP or control growth plates
(data not shown). Taken together, these findings indicate
that D469del-COMP induces cell death in the growth-
plate chondrocytes by necroptosis.
Discussion
COMP plays an important role in homeostasis of the
growth plate and articular cartilage, but the exact func-
tion or functions still remain to be defined.11–13,16,17,53,54
Absence of COMP causes mild perturbations in the
growth plate, whereas D469del-COMP causes cata-
strophic effects, such as premature loss of chondrocytes,
which translates into pseudoachondroplasia, a well-char-
acterized form of dwarfism.22,23,55 Despite cross-sec-
tional information from iliac crest biopsies about growth
plate disturbance in humans and transgenic mice ex-
pressing mutant COMP, the pathological processes in
growth-plate chondrocytes resulting from D469del-
COMP retention have not been characterized during de-
velopment and growth. In the present study, we used
doxycycline-inducible transgenic mice that express
D469del-COMP in growth-plate chondrocytes to study
the effects of D469del-COMP on growth-plate develop-
ment. We show that, although D469del-COMP retention
begins very early, before birth, it does not become per-
vasive until after birth, at which time it establishes a
proapoptotic environment. Later in skeletal maturation,
the pervasive D469del-COMP retention was associated
with the onset of cell death and expression of mRNAsinvolved in ROS metabolism, antioxidant function, and
inflammation. Importantly, by reducing the UPR Chop-
mediated response, D469del-COMP was secreted from
the chondrocytes, and the growth plate had a more nor-
mal appearance. These results have important implica-
tions for therapy.
Babies with pseudoachondroplasia have normal birth
parameters, but show decreased linear growth by 2
years of age, and then very little long-bone growth after
the age of 6 years. Mouse long-bone growth is essentially
complete by 8 weeks, when the growth plate becomes
quiescent. Similar to pseudoachondroplasia babies, the
D469del-COMP mice appear normal at birth. However,
the D469del-COMP mouse at 1 month had a dwarfed
appearance, with an abnormal protuberant rib cage, sim-
ilar to the human pectus carinatum seen in pseudoachon-
droplasia (Figure 5). There was significant reduction in
long bones of the fore and hind limbs, with a 12% reduc-
tion in tibial length (Figure 4). Moreover, the digits in the
fore limb were short (Figure 5). The face in pseudoachon-
droplasia is very angular, and the head circumference is
normal. Similarly, the D469del-COMP mouse shows a
reduction in snout length and a smaller cranial vault
(Figure 5). Thus, we show that the D469del-COMP
mice manifest most of the skeletal abnormalities of
pseudoachondroplasia and truly mimic the human
dwarfing condition.
Analysis of the growth plate showed that intracellular
retention of D469del-COMP was limited to a few chon-
drocytes at E15.5. At birth (P1), intracellular retention of
D469del-COMP had a patchy distribution in the growth
plate that became extensive by P21 (Figure 2). Of note,
only at P21 did gross growth plate changes become
obvious, with fewer chondrocytes and reduced growth-
plate width (Figures 1 and 3). The timing of cell death in
the D469del-COMP growth plate followed the temporal
pattern of intracellular retention, suggesting that signifi-
cant retention in most growth-plate chondrocytes was
Figure 7. Loss of Chop reduces D469del-
COMP-induced cellular stress. Quantitation of
Chop, Xbp1, Gadd45a, Gadd34, Ero1b, and
Grp78 mRNAs from hind-limb joints of 1-month-
old C57BL/6 (control), Chop/, D469del-
COMP, and Chop/ D469del-COMP mice.
D469del-COMP increases expression of specific
ER stress mRNAs. The absence of Chop in the
presence of D469del-COMP lowers the expres-
sion of these stress genes. *P  0.05.necessary to induce cell death (Figure 3).
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cell death, transcriptome analysis was performed on
hind-limb joints from mice at ages P1 to 4 weeks. In-
creases in proapoptotic genes (eg, Chop) and repres-
sions of antiapoptotic factors (eg, Bcl-2 family) were
found at P1 and P7, even though there was relatively little
D469del-COMP retention. Despite the early apoptotic
stimulus, D469del-COMP chondrocytes survived until 3
weeks, when D469del-COMP retention became wide-
spread. Of note, select inflammatory markers showed a
dramatic increase at that time point, but subsequently
returned to normal values. In the Chop/ D469del-
COMP mouse, these same inflammatory transcripts were
Figure 8. AIF and H2AX immunostaining of C57BL/6 and D469del-COMP
growth-plate chondrocytes. AIF and H2AX antibodies were used to localize
these necroptotic proteins; DAPI staining marks the nucleus. Dashed outlines
mark the nucleus, regardless of stain. A–L: AIF and DAPI staining of C57BL/6
(A–F) and D469del-COMP (G–L) growth plates of 1-month-old mice. AIF was
observed in the nucleus of D469del-COMP chondrocytes (J–L), but only in
the cytoplasm of the controls (D–F). Asterisks mark AIF localization. M–O:
H2AX staining of C57BL/6 (M) and D469del-COMP (N–O) growth plates of
1-month-old mice. H2AX was elevated in D469del-COMP growth plate,
compared with control. Scale bar  50 m (A–C and G–I). Boxed area
locates the image of a single nucleus, shown at higher magnification in the
next row. Original magnification, 20. Inset cells enlarged digitally.reduced two-fold, indicating that retained D469del-COMP elevates these inflammatory mRNAs but that
D469del-COMP in the extracellular matrix does not. An
increase in ROS metabolism genes and antioxidant
genes coincided with the widespread cell death. ER
stress is known to stimulate ROS production and oxida-
tive stress, thereby causing inflammation.56,57 Excessive
and prolonged oxidative stress mediates cell death
through caspase-independent mechanisms, and specif-
ically through necroptosis.58 Mild oxidative stress leads
to caspase cleavage and apoptosis.58 AIF, a necroptosis
executioner, and its binding partner, H2AX, were both
elevated in D469del-COMP growth-plate chondrocytes
(Figure 8). Our results show that at P1 to P7 apoptosis
was stimulated when D469del-COMP retention and oxi-
dative stress were minimal. However, necroptosis took
over at 3 to 4 weeks, when extensive D469del-COMP
retention generated excessive oxidative stress.
Studies in a mouse model of MED/EDM1 caused by a
T585M COMP mutation suggested that Chop plays a role
in mutant COMP-induced cell death.42 This mouse
showed little intracellular retention, but had increased
apoptosis and decreased chondrocyte proliferation. Sim-
ilarly, Chop mRNA was increased at P1 and P7 in our
D469del-COMP mice, leading us to examine the effect of
loss of Chop on the retention of D469del-COMP. Ab-
sence of Chop resulted in less retention of D469del-
COMP, with export to the ECM (Figure 6). Importantly, the
loss of Chop in the Chop/ D469del-COMP mice results
in an increase in proliferation and decrease in cell death,
as assessed by PCNA and TUNEL staining, respectively
(Figure 6). Additionally, expression of several stress-re-
lated genes were depressed in the Chop/ D469del-
COMP mouse, compared with the control mice (Figures 6
and 7). These results indicate that Chop-mediated cellu-
lar stress is a consequence of D469del-COMP retention,
rather than of the presence of D469del-COMP in the
extracellular matrix, as was previously suggested.32,42
This also suggests that the ER quality control systems,
particularly the Chop arm, prevent D469del-COMP ex-
port, and that by interrupting these sensing mechanisms
D469del-COMP can be secreted.
Our unique transgenic mouse, which expresses
D469del-COMP in a tissue-specific manner, is a substantial
improvement over other models, because it recapitulates
both the chondrocyte pathology and the skeletal abnor-
Figure 9. Schematic of D469del-COMP growth plate pathology during mat-
uration of the mouse skeletal. Shortly after birth, there is little D469del-COMP
intracellular retention and very little cell death. As retention increases, there
is induction of oxidative stress and inflammation markers and abundant cell
death occurs throughout the growth plate, rather than being limited to the
hypertrophic zone.
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We show the progressive nature of D469del-COMP ac-
cumulation and chondrocyte loss, which now explains
the deceleration of human long-bone growth in pseudoa-
chondroplasia. Although COMP accumulation at birth is
minimal, it steadily increases in all of the growth-plate
chondrocytes. Chondrocytes are able to maintain normal
function initially, but the D469del-COMP intracellular load
subsequently appears to overwhelm the cellular coping
systems, leading to cell death. These novel findings sug-
gest a molecular model in which D469del-COMP triggers
apoptosis signaling soon after birth (Figure 9). Later,
when most chondrocytes are retaining D469del-COMP,
oxidative stress leads to inflammation and DNA damage,
and finally chondrocyte cell death occurs through
necroptosis. Also shown is that Chop plays a significant
role in the chondrocyte intracellular pathology. Chop and
other proapoptotic mRNAs were elevated from P1 to P7,
but antiapoptotic mRNAs were decreased. Despite unfa-
vorable changes in apoptotic and survival mRNAs,
growth-plate chondrocytes survived until P21, when all
showed significant D469del-COMP intracellular retention
and inflammation and ROS stress was triggered. Our
results suggest that adverse molecular events occur be-
fore clinical diagnosis (at approximately 2 to 3 years of
age in humans and by 3 weeks of age in mice). Thera-
peutics would be most effective if administered very
early, before oxidative stress and inflammation re-
sponses are mounted. The tolerance of growth-plate
chondrocytes to intracellular D469del-COMP may define
a therapeutic window in which treatments would be the
most effective before the initiation of inflammation and
reactive oxygen stress.
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